Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-5 of 5 for

Edit search filters
  1. A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

    Jacksonville, FL

  2. A Study of Intravitreal REGN2176-3 in Patients with Neovascular ("Wet") Age-Related Macular Degeneration

    Jacksonville, FL

  3. A Study of the Safety and Effectiveness of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration

    Jacksonville, FL

  4. A Study to Compare Circadian Phase in Patients with Wet Macular Degeneration to Controls Without Ocular Pathology

    Jacksonville, FL

  5. A Study to Determine if the Fluid that Collects in the Retina (Macular Edema) Changes Throughout the Course of a Single Day

    Rochester, MN

.

Mayo Clinic Footer